| symbol | subject | date & time | rating |
|
|
looks like a leak may have made it through some investors/houses...3:59 PM EDT0.3702,0000.0150190073:59 PM EDT0.3806,5000.0250800793:54 PM EDT0.3802000.0250990023:54 PM EDT0.3751,0000.0200800073:51 PM EDT0.3755,0000.0200800073:48 PM EDT0.3808,0000... |
5/23/2013 5:55:46 PM |
|
|
|
2:38 PM EDT 0.360 10,000 0.005 073 0192:38 PM EDT 0.360 57,500 0.005 073 0802:38 PM EDT 0.360 50,000 0.005 073 080> |
5/23/2013 3:01:19 PM |
|
|
|
3:59 PM EDT0.3558,00000010803:55 PM EDT0.3552,00000010803:55 PM EDT0.3553,00000010803:53 PM EDT0.3552,50000790803:53 PM EDT0.350500-0.0050010793:53 PM EDT0.350500-0.0050010793:53 PM EDT0.3503,000-0.0050010393:53 PM EDT0.35011,500-0.0050010793:53 P... |
5/22/2013 4:20:37 PM |
2 |
|
|
eom |
5/17/2013 1:50:47 PM |
2 |
|
|
dont forget though h2 always seems to bring on more revenues as cash inflows increase with product delivery...personnally i hope it dips a little more as i want to increase my position, i really like this junior, technology works and majors are ... |
5/9/2013 3:05:48 PM |
2 |
|
|
This is exponential growth my friends:) ProMetic Reports Highlights of Its 2012 Annual and Special Meeting of Shareholders and Its First Quarter 2013 Financials Results- Revenues of $4.4 million in Q1 2013, an increase of $3.3 million compared to... |
5/8/2013 12:13:08 PM |
2 |
|
|
I couldn't agree more, mtnbkr. The main risk facing PLI at this juncture is 'execution risk' and frankly that is relatively small. In the protein division, revenue capacity of PLI's two manufacturing plants ($150M - Laval for PP... |
5/7/2013 3:21:50 PM |
2 |
|
|
the p-capt filter , developped by PLI with its partner the american red cross by the way... is only one of the applications of PLI's technology... the revenues are growing fast, not because of the p-capt filter, but because our other partne... |
5/7/2013 3:17:11 PM |
2 |
|
|
P-Capt® is the only approved product proven to be effective for the removal of prion infectivity from red blood cell concentrate prior to transfusion. It has been evaluated extensively by the UK Blood Services (including the National Blood Se... |
5/6/2013 10:46:29 PM |
2 |
|
|
and PLI has the product ready, thanks to a collaboration with the AMERICAN RED CROSS.http://www.marketwire.com/press-release/prometic-life-sciences-inc-p-captr-filtration-prevents-transmission-endogenous-blood-tsx-pli-1656113.htm |
5/6/2013 10:43:41 PM |
2 |
|
5/21/2013 11:06:11 AM
| 137 reads
| overall quality: 2
and on track:Revenues of $4.4 million in Q1 2013, an increase of $3.3 million compared to Q1 2012Revenues expected to exceed $11.0 million by the end of June 2013, compared to $7.4 million for the first half of 20122013 revenues expected to sig...
5/15/2013 3:40:13 PM
| 127 reads
| overall quality: 3
Having listening to the CC, I'm out of there with a clear conclusion: The PPPS division is worth much, much, much more than the 3$ we've been talking about! :-) We already knew that CNBG will bring in about 22-24M$ gross margin. Octopha...
5/10/2013 1:39:09 PM
| 61 reads
| overall quality: 3
revenue jump again: ProMetic Reports Highlights of Its 2012 Annual and Special Meeting of Shareholders and Its First Quarter 2013 Financials Results- Revenues of $4.4 million in Q1 2013, an increase of $3.3 million compared to Q1 2012 - Revenu...
4/30/2013 8:52:00 AM
| 110 reads
| overall quality: 2
PROMETIC AND SARTORIUS STEDIM BIOTECH (“SSB”) JOIN FORCES TO PROMOTE NOVEL TURNKEY SOLUTION FOR PRODUCING PLASMA-DERIVED THERAPEUTICSProMetic BioProduction's plasma purification facility to become the technological showroom for ...
4/24/2013 12:28:56 PM
| 103 reads
| overall quality: 2
I couldn't agree more, mtnbkr. The main risk facing PLI at this juncture is 'execution risk' and frankly that is relatively small. In the protein division, revenue capacity of PLI's two manufacturing plants ($150M - Laval for PP...
4/23/2013 2:04:32 PM
| 106 reads
| overall quality: 2
As of 11:59pm ET April 22nd, 2013FilingDateTransactionDateInsider NameOwnershipTypeSecuritiesNature of transaction# or value acquired or disposed ofPriceApr 19/13Apr 19/13Dumais, FrédéricIndirect OwnershipCommon Shares10 - Acquisit...
4/18/2013 3:20:04 PM
| 174 reads
| overall quality: 2
As of 11:59pm ET April 16, 2013FilingDateTransactionDateInsider NameOwnershipTypeSecuritiesNature of transaction# or value acquired or disposed ofPriceFeb 15/13Feb 14/13Wygodny, BenjaminIndirect OwnershipCommon Shares11 - Acquisition carried out...
4/16/2013 3:33:23 PM
| 192 reads
| overall quality: 4
Hi all, I copy below the question I emailed to Fred and his reponse. Btw, the rev estimates in the response are annual. Glta Stockman6767 ----------------------------------------- Hi Again Fred, I am wondering if we have an estimate of what thi...
4/12/2013 9:11:15 AM
| 238 reads
| overall quality: 2
ProMetic Life Sciences Inc. Begins Trading on OTCQX®ProMetic Life Sciences Inc. PLI4/12/2013 7:00:00 AMProMetic Life Sciences Inc. Begins Trading on OTCQX®NEW YORK, April 12, 2013 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), ope...
3/14/2013 8:17:00 AM
| 151 reads
| overall quality: 2
US FDA GRANTS ORPHAN-DRUG DESIGNATION TO PROMETIC'S PLASMA-DERIVED PLASMINOGEN DRUG US FDA Grants Orphan-Drug Designation to ProMetic's Plasma-Derived Plasminogen DrugLAVAL, QUEBEC and ROCKVILLE, MARYLAND and TAIPEI, TAIWAN--(Marketwire ...
Stockhouse.com: Taking
it to the street
